Vastned (VASTB) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
22 Jun, 2026Executive summary
Completed a reverse cross-border merger on 1 January 2025, unifying operations under a single entity headquartered in Belgium with dual Euronext listings.
Achieved operational synergies of €2.0–2.5 million annually, optimized debt financing, and increased share liquidity.
Maintained a high-quality, diversified retail property portfolio across the Netherlands, France, Belgium, and Spain, with a 98.7% occupancy rate at year-end.
Focused on value creation within the existing portfolio and cautious, sustainable growth.
Financial highlights
Gross rental income was €68.5 million in 2024, down from €72.1 million in 2023, mainly due to divestments.
Net result for 2024 was €10.6 million, compared to €11.3 million in 2023.
EPRA earnings per share were €2.38 (2023: €2.81).
Dividend per share remained stable at €2.30, with an additional exceptional interim dividend of €1.00 paid in January 2025.
Share price at year-end was €27.60, reflecting a -10.4% decrease year-over-year and a 36% discount to net asset value.
Debt ratio increased to 31.5% (2023: 25.3%), with a loan-to-value of 32.1%.
Outlook and guidance
EPRA result per share for 2025 is expected between €1.95 and €2.05.
2025 will focus on full integration post-merger, organizational adjustment, and confirmation of strategic objectives.
Refinancing completed for €345 million in credit lines, with interest rate hedges in place to stabilize future financing costs.
Latest events from Vastned
- High occupancy, stable results, improved leverage, and merger progress define H1 2024.VASTB
Q2 202424 Jun 2026 - Portfolio growth, high occupancy, and merger synergies offset by rising financing costs in 2026.VASTB
Q4 202523 Jun 2026 - EPRA earnings declined, net result rose, and a merger with interim dividends was approved.VASTB
Q3 202422 Jun 2026 - Portfolio value up 1.3%, net result surges, and 2025 EPRA EPS guidance reaffirmed.VASTB
Q1 202522 Jun 2026 - EPRA earnings and portfolio value grew, while leverage improved and occupancy stayed high.VASTB
Q1 202625 May 2026 - Portfolio value up 2.1%, occupancy at 98.6%, and 2025 guidance raised after strong nine months.VASTB
Q3 202527 Oct 2025 - EPRA earnings per share guidance raised to €2.00–€2.10 as portfolio value and occupancy remain strong.VASTB
Q2 202528 Jul 2025